ACCESS Newswire
14 May 2019, 17:07 GMT+10
Pharma Industry Veteran and Licensed Pharmacist Rajneesh Taneja, PhD.
WALNUT CREEK, CA / ACCESSWIRE / May 14, 2019 / Vivacitas Oncology, Inc. ('Vivacitas' or the 'Company') continues to attract top talent when it comes to precision drug development. With this week's addition of scientific advisor Rajneesh Taneja, PhD., the company has further fortified its access to experienced intellectual capital.
'Raj is an exceptional healthcare professional, with in-depth understanding of patient needs, treatment limitations and potential opportunities. His tenacity to solve clinically challenging problems makes him truly special. I became familiar with his work during our mutual tenure at TAP Pharmaceuticals' said CEO Pramod Gupta, PhD. 'Having him join our scientific advisory board is a big deal. He can help us leap-frog in an effective manner with keen focus on the big picture' Dr. Gupta went on to say.
Rajneesh Taneja, PhD. currently serves as the Vice President at Global Alliance for TB Drug Development where he is responsible for designing and developing unique products to meet a wide range of patients' needs. Previously Rajneesh worked at Takeda Pharmaceuticals and at Johns Hopkins Hospital. Dr. Taneja received his undergraduate degree in Pharmacy from the Delhi University, India and he earned his PhD. in Biopharmaceutics & Industrial Pharmacy from the University of Maryland at Baltimore, MD. He's also an office holder at the American Association of Pharmaceutical Scientists (AAPS).
Dr. Taneja went on to state, 'Vivacitas pipeline comprises drugs with unique promise for patients with GBM and other widely known cancers. I strongly believe these drugs could be developed in a manner which could offer compelling alternatives to cancer patients and healthcare professionals.'
ABOUT VIVACITA ONCOLOGY:
A privately held biopharmaceutical company co-founded in 2015 by Dr. Joseph Rubinfeld and Infusion 51a. Vivacitas is focused on acquiring mid-to-late-stage oncology assets with the goal to make the chemotherapy more effective for patients.
For further information please visit www.vivaoncology.com.
Forward-Looking Statements
Certain statements, other than purely historical information, including estimates, projections, statements relating to our business plans, objectives, and expected operating results, and the assumptions upon which those statements are based, are forward-looking statements. These forward-looking statements generally are identified by the words 'believes,' 'project,' 'expects,' 'anticipates,' 'estimates,' 'intends,' 'strategy,' 'plan,' 'may,' 'will,' 'would,' 'will be,' 'will continue,' 'will likely result,' and similar expressions. Forward-looking statements are based on current expectations and assumptions that are subject to risks and uncertainties which may cause actual results to differ materially from the forward-looking statements. Our ability to predict results or the actual effect of future plans or strategies is inherently uncertain. Factors which could have a material adverse effect on our operations and future prospects on a consolidated basis include, but are not limited to: changes in economic conditions, legislative/regulatory changes, availability of capital, interest rates, competition, and generally accepted accounting principles. These risks and uncertainties should also be considered in evaluating forward-looking statements and undue reliance should not be placed on such statements.
CONTACT:
Jeff Stephens
312-265-6700
[email protected]
SOURCE: Vivacitas Oncology, Inc.
Get a daily dose of Memphis Sun news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Memphis Sun.
More InformationDHARAMSHALA, India: The Dalai Lama turned 90 on July 6, celebrated by thousands of followers in the Himalayan town of Dharamshala,...
ZAGREB, Croatia: A massive concert by popular Croatian singer Marko Perković, known by his stage name Thompson, has drawn widespread...
WASHINGTON, D.C.: Elon Musk's entry into the political arena is drawing pushback from top U.S. officials and investors, as his decision...
CULVER CITY, California: TikTok is preparing to roll out a separate version of its app for U.S. users, as efforts to secure a sale...
WASHINGTON, D.C.: President Donald Trump claimed he was unaware that the term shylock is regarded as antisemitic when he used it in...
PARIS, France: A strike by French air traffic controllers demanding improved working conditions caused significant disruptions during...
OTTAWA, Canada: With Canada Post struggling to maintain operations amid labour unrest, rivals like FedEx and UPS are stepping in to...
NEW YORK, New York - U.S. and global markets showed a mixed performance in Tuesday's trading session, with some indices edging higher...
PARIS, France: French military and intelligence officials have accused China of orchestrating a covert campaign to damage the reputation...
NEW DELHI, India: Birkenstock is stepping up its efforts to protect its iconic sandals in India, as local legal representatives conducted...
HONG KONG: China has fired back at the European Union in an escalating trade dispute by imposing new restrictions on medical device...
NEW YORK, New York - Monday's trading session saw mixed performances across U.S. and global markets, with several major indices posting...